Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease


The formation of antibodies to infliximab (ATIs) is closely associated with the loss of response to infliximab in patients with inflammatory bowel disease (IBD). We evaluated the clinical utility of a novel method to measure serum ATI levels in the presence of infliximab. ATI levels were measured using a novel immunoassay and the conventional method in 58… (More)
DOI: 10.1007/s00535-011-0474-y


7 Figures and Tables

Slides referencing similar topics